Which statement best contrasts PK vs PD variability?

Which statement best contrasts PK vs PD variability?

• A. PK variability relates to differences in drug concentration at the site of action; PD variability relates to differences in response to the same concentration.
• B. PK variability relates to receptor sensitivity; PD to absorption rate.
• C. PK variability to genetic factors; PD to environmental factors.
• D. PK variability to efficacy only; PD to toxicity only.

Answer: (A)

Understanding how variability manifests in pharmacokinetics versus pharmacodynamics is key here. Pharmacokinetic variability shows up as differences in drug concentrations achieved in the body, at the site of action, due to factors like absorption, distribution, metabolism, and excretion. In contrast, pharmacodynamic variability reflects how those same concentrations produce different effects in different individuals, which depends on receptor sensitivity, signaling pathways, and downstream responses. The statement that best contrasts them is that PK variability relates to differences in drug concentration at the site of action, whereas PD variability relates to differences in response to the same concentration. The other options mix up what PK and PD describe (for example, receptor sensitivity and absorption rate belong to the opposite domains), or claim that one domain only affects efficacy or toxicity, which isn’t accurate since both PK and PD can influence both efficacy and toxicity and are shaped by a mix of genetic, environmental, and physiological factors.

Understanding how variability manifests in pharmacokinetics versus pharmacodynamics is key here. Pharmacokinetic variability shows up as differences in drug concentrations achieved in the body, at the site of action, due to factors like absorption, distribution, metabolism, and excretion. In contrast, pharmacodynamic variability reflects how those same concentrations produce different effects in different individuals, which depends on receptor sensitivity, signaling pathways, and downstream responses.

The statement that best contrasts them is that PK variability relates to differences in drug concentration at the site of action, whereas PD variability relates to differences in response to the same concentration. The other options mix up what PK and PD describe (for example, receptor sensitivity and absorption rate belong to the opposite domains), or claim that one domain only affects efficacy or toxicity, which isn’t accurate since both PK and PD can influence both efficacy and toxicity and are shaped by a mix of genetic, environmental, and physiological factors.